A useful answer needs

a basis the clinician can examine.

A broader warning from health governance

WHO's 2024 guidance on large multi-modal models

describes potential uses across clinical care, research,

education and administration. It also warns that

generated information may be false, inaccurate, biased

or incomplete. These are general concerns about a

class of technology, not findings about the Mayo

product. [13]

The guidance raises automation bias: users may give an

automated output too much weight or miss errors

because the system appears authoritative. It calls for

stakeholder involvement, transparency and evaluation,

including independent assessment after deployment. Its

central relevance here is the need to evaluate a tool in

the conditions where people actually use it. [13]

What a useful evaluation would measure

Graymedy's proposed standard begins with a defined

task. A system used to retrieve background information

should not be assessed as though it were independently

diagnosing a patient. Evaluators should specify who

uses it, what they are expected to verify and which

errors would change care. Those boundaries make

results interpretable.

A test set should include cases where the correct

response is uncertainty, a request for missing

information or recognition that the question lies outside

the system's role. Reporting only successful examples

gives little insight into reliability. The harder cases reveal

whether confident language remains connected to

adequate evidence.

The answer and its basis

FDA describes the value of plain-language information

about required inputs, how they are obtained, data

quality, methods, development data and clinical

validation. Patient-specific information and known

limitations help a professional assess a

recommendation. The purpose is to enable independent

review, rather than making an output the primary basis

of judgment. [14]

In practical terms, the user needs a route from the

answer back to what supports it. Does the cited study

address the question asked? Is the population relevant?

Are important exclusions visible? A tool that makes

those checks easier offers a different experience from

one that provides a polished answer with a difficult trail

back to evidence.

The next evidence to watch

The strongest follow-up reporting would describe

real-world performance, errors, workload and

patient-relevant outcomes using clear comparisons. It

would show where the tool helps and where it needs

restraint. For this week's launch, the defensible

conclusion is narrower: access to a new information

resource has expanded, while its practical effect needs

transparent evaluation.

FROM ANSWER TO DECISION / AN EDITORIAL REVIEW FRAMEWORK

01

Check the source

Does it support this claim?

02

Check the fit

Does it apply to this patient?

03

Make the decision

Explain options and uncertainty.